Global Constipation Treatment Market Overview And Scope:
Global Constipation Treatment Market Size was estimated at USD 6449.44 million in 2022 and is projected to reach USD 8131.92 million by 2028, exhibiting a CAGR of 3.94% during the forecast period.
The Global Constipation Treatment Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Constipation Treatment utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Takeda, SGYP, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Abbott, AstraZeneca, Cosmo Pharmaceuticals, Sanofi, Daewoong, Bayer, Prestige Brands, Janssen Pharmaceutical, Shionogi, Albireo Pharma, Renexxion
Global Constipation Treatment Market Segmentation
By Type, Constipation Treatment market has been segmented into:Chronic Idiopathic Constipation
Irritable Bowel Syndrome with Constipation
Opioid Induced Constipation
By Application, Constipation Treatment market has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Constipation Treatment market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Constipation Treatment market.
Top Key Players Covered in Constipation Treatment market are:
Takeda
SGYP
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Abbott
AstraZeneca
Cosmo Pharmaceuticals
Sanofi
Daewoong
Bayer
Prestige Brands
Janssen Pharmaceutical
Shionogi
Albireo Pharma
Renexxion
Objective to buy this Report:
1. Constipation Treatment analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Constipation Treatment market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Constipation Treatment Market by Type
5.1 Constipation Treatment Market Overview Snapshot and Growth Engine
5.2 Constipation Treatment Market Overview
5.3 Chronic Idiopathic Constipation
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Chronic Idiopathic Constipation: Geographic Segmentation
5.4 Irritable Bowel Syndrome with Constipation
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Irritable Bowel Syndrome with Constipation: Geographic Segmentation
5.5 Opioid Induced Constipation
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Opioid Induced Constipation: Geographic Segmentation
Chapter 6: Constipation Treatment Market by Application
6.1 Constipation Treatment Market Overview Snapshot and Growth Engine
6.2 Constipation Treatment Market Overview
6.3 Hospital Pharmacies
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital Pharmacies: Geographic Segmentation
6.4 Retail Pharmacies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Retail Pharmacies: Geographic Segmentation
6.5 Online Pharmacies
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Online Pharmacies: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Constipation Treatment Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Constipation Treatment Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Constipation Treatment Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 TAKEDA
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 SGYP
7.4 SUCAMPO PHARMACEUTICALS
7.5 IRONWOOD PHARMACEUTICALS
7.6 ABBOTT
7.7 ASTRAZENECA
7.8 COSMO PHARMACEUTICALS
7.9 SANOFI
7.10 DAEWOONG
7.11 BAYER
7.12 PRESTIGE BRANDS
7.13 JANSSEN PHARMACEUTICAL
7.14 SHIONOGI
7.15 ALBIREO PHARMA
7.16 RENEXXION
Chapter 8: Global Constipation Treatment Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Chronic Idiopathic Constipation
8.2.2 Irritable Bowel Syndrome with Constipation
8.2.3 Opioid Induced Constipation
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital Pharmacies
8.3.2 Retail Pharmacies
8.3.3 Online Pharmacies
Chapter 9: North America Constipation Treatment Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Chronic Idiopathic Constipation
9.4.2 Irritable Bowel Syndrome with Constipation
9.4.3 Opioid Induced Constipation
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital Pharmacies
9.5.2 Retail Pharmacies
9.5.3 Online Pharmacies
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Constipation Treatment Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Chronic Idiopathic Constipation
10.4.2 Irritable Bowel Syndrome with Constipation
10.4.3 Opioid Induced Constipation
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital Pharmacies
10.5.2 Retail Pharmacies
10.5.3 Online Pharmacies
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Constipation Treatment Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Chronic Idiopathic Constipation
11.4.2 Irritable Bowel Syndrome with Constipation
11.4.3 Opioid Induced Constipation
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital Pharmacies
11.5.2 Retail Pharmacies
11.5.3 Online Pharmacies
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Constipation Treatment Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Chronic Idiopathic Constipation
12.4.2 Irritable Bowel Syndrome with Constipation
12.4.3 Opioid Induced Constipation
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital Pharmacies
12.5.2 Retail Pharmacies
12.5.3 Online Pharmacies
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Constipation Treatment Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Chronic Idiopathic Constipation
13.4.2 Irritable Bowel Syndrome with Constipation
13.4.3 Opioid Induced Constipation
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital Pharmacies
13.5.2 Retail Pharmacies
13.5.3 Online Pharmacies
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Constipation Treatment Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Chronic Idiopathic Constipation
14.4.2 Irritable Bowel Syndrome with Constipation
14.4.3 Opioid Induced Constipation
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital Pharmacies
14.5.2 Retail Pharmacies
14.5.3 Online Pharmacies
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Constipation Treatment Scope:
|
Report Data
|
Constipation Treatment Market
|
|
Constipation Treatment Market Size in 2025
|
USD XX million
|
|
Constipation Treatment CAGR 2025 - 2032
|
XX%
|
|
Constipation Treatment Base Year
|
2024
|
|
Constipation Treatment Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Takeda, SGYP, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Abbott, AstraZeneca, Cosmo Pharmaceuticals, Sanofi, Daewoong, Bayer, Prestige Brands, Janssen Pharmaceutical, Shionogi, Albireo Pharma, Renexxion.
|
|
Key Segments
|
By Type
Chronic Idiopathic Constipation
Irritable Bowel Syndrome with Constipation
Opioid Induced Constipation
By Applications
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
|
